OBJECTIVE: Mycoplasma hominis is a well recognized extragenital pathogen. However, it is an uncommon cause of respiratory infections in critically ill patients admitted to the intensive care unit (ICU). DESIGN AND SETTING: Prospective clinical investigation in a 21-bed ICU in a university hospital. PATIENTS: Seven patients requiring intensive care who developed a ICU-acquired pneumonia in which M. hominis was recovered from bronchoalveolar lavage and pleural fluid cultures. INTERVENTIONS: M. hominis was isolated in all patients by use of conventional bacteriological cultures. All strains were identified by 16S rRNA gene sequencing analysis. Patients' charts were reviewed for each case of infection. RESULTS: Seven strains of M. hominis were isolated during a 4-year period. All of these isolates were recovered from adult men admitted to the ICU and all had clinical signs of pneumonia. In three patients treatment for M. hominis with quinolones was associated with a good clinical response. CONCLUSION: Suspicion of M. hominis pneumonia must be heightened particularly in critically ill patients. Therefore an understanding of the microbiology of this organism is essential to successfully treat patients with these infections that are not ordinarily covered with standard antibiotic therapy.
OBJECTIVE:Mycoplasma hominis is a well recognized extragenital pathogen. However, it is an uncommon cause of respiratory infections in critically illpatients admitted to the intensive care unit (ICU). DESIGN AND SETTING: Prospective clinical investigation in a 21-bed ICU in a university hospital. PATIENTS: Seven patients requiring intensive care who developed a ICU-acquired pneumonia in which M. hominis was recovered from bronchoalveolar lavage and pleural fluid cultures. INTERVENTIONS:M. hominis was isolated in all patients by use of conventional bacteriological cultures. All strains were identified by 16S rRNA gene sequencing analysis. Patients' charts were reviewed for each case of infection. RESULTS: Seven strains of M. hominis were isolated during a 4-year period. All of these isolates were recovered from adult men admitted to the ICU and all had clinical signs of pneumonia. In three patients treatment for M. hominis with quinolones was associated with a good clinical response. CONCLUSION: Suspicion of M. hominispneumonia must be heightened particularly in critically illpatients. Therefore an understanding of the microbiology of this organism is essential to successfully treat patients with these infections that are not ordinarily covered with standard antibiotic therapy.
Authors: Elpis Giantsou; Nikolaos Liratzopoulos; Eleni Efraimidou; Maria Panopoulou; Eleonora Alepopoulou; Sofia Kartali-Ktenidou; George I Minopoulos; Spyros Zakynthinos; Konstantinos I Manolas Journal: Intensive Care Med Date: 2005-09-07 Impact factor: 17.440
Authors: Elie Azoulay; Corinne Alberti; Isabelle Legendre; Christian Brun Buisson; Jean Roger Le Gall Journal: Intensive Care Med Date: 2004-11-04 Impact factor: 17.440
Authors: F J van Kuppeveld; J T van der Logt; A F Angulo; M J van Zoest; W G Quint; H G Niesters; J M Galama; W J Melchers Journal: Appl Environ Microbiol Date: 1992-08 Impact factor: 4.792
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-01-31 Impact factor: 17.440
Authors: Daria A Burmistrova; Sergey V Tillib; Dmitry V Shcheblyakov; Inna V Dolzhikova; Dmitry N Shcherbinin; Olga V Zubkova; Tatiana I Ivanova; Amir I Tukhvatulin; Maxim M Shmarov; Denis Y Logunov; Boris S Naroditsky; Aleksandr L Gintsburg Journal: PLoS One Date: 2016-03-10 Impact factor: 3.240